Boston investment manager founded in 1977 by Jeremy Grantham, Dick Mayo and Eijk van Otterloo; invests on the view that asset prices revert to the mean, and managed $155 billion at its 2007 peak.
Managed by Jeremy Grantham
20 letters, 2007 to 2026
AUM: $81.0B · Form ADV, 11 May 2026
| i | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nasdaq: MSFT | Current | Services-Prepackaged Software | COM | 6,808,753 | -7,573 | -0.1% | 0.09% | $3.5B | +$950M | 7.49% | $3.60T | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: META | Current | Services-Computer Programming, Data Processing, Etc. | CL A | 3,148,152 | -298,565 | -8.7% | $2.3B | +$341M | 4.90% | $1.43T | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: GOOGL | Current | Services-Computer Programming, Data Processing, Etc. | CAP STK CL C | 6,235,765 | +67,835 | +1.1% | $2.1B | -$59M | 4.60% | $3.25T | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: AAPL | Current | Electronic Computers | COM | 6,028,178 | -820,604 | -12.0% | 0.04% | $2.0B | +$26M | 4.31% | $4.98T | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: TMO | Current | Measuring & Controlling Devices, NEC | COM | 2,966,718 | +227,527 | +8.3% | 0.80% | $2.0B | +$629M | 4.30% | $248B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: JNJ | Current | Pharmaceutical Preparations | COM | 6,956,949 | -153,184 | -2.2% | 0.29% | $1.8B | +$36M | 3.95% | $643B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: AMZN | Current | Retail-Catalog & Mail-Order Houses | COM | 6,251,591 | +114,665 | +1.9% | 0.06% | $1.6B | +$95M | 3.34% | $2.67T | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: LRCX | Current | Special Industry Machinery, NEC | COM NEW | 4,697,045 | -767,681 | -14.0% | 0.38% | $1.5B | -$825M | 3.31% | $254B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: TXN | Current | Semiconductors & Related Devices | COM | 4,686,735 | +12,329 | +0.3% | 0.51% | $1.3B | -$81M | 2.82% | $261B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: V | Current | Services-Business Services, NEC | COM CL A | 3,393,457 | +75,263 | +2.3% | $1.2B | +$81M | 2.62% | $750B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: AVGO | Current | Semiconductors & Related Devices | COM | 3,304,154 | +37,114 | +1.1% | 0.07% | $1.2B | -$74M | 2.49% | $1.65T | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: NVDA | Current | Semiconductors & Related Devices | COM | 4,545,142 | -126,830 | -2.7% | 0.02% | $1.0B | +$103M | 2.23% | $3.03T | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: UNH | Current | Hospital & Medical Service Plans | COM | 2,796,457 | -28,565 | -1.0% | 0.31% | $1.0B | -$148M | 2.20% | $296B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: MA | Current | Services-Business Services, NEC | CL A | 1,850,115 | +31,372 | +1.7% | $1.0B | +$86M | 2.19% | $545B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: NFLX | Current | Services-Video Tape Rental | COM | 13,626,324 | +3,276,320 | +31.7% | 0.33% | $948M | +$209M | 2.03% | $233B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: ABT | Current | Pharmaceutical Preparations | COM | 8,966,588 | +172,511 | +2.0% | 0.52% | $886M | +$88M | 1.90% | $180B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Eli Lilly | NYSE: LLY | Current | Pharmaceutical Preparations | COM | 753,925 | +9,959 | +1.3% | 0.08% | $872M | -$20M | 1.87% | $1.20T | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 |
| NYSE: USB | Current | National Commercial Banks | COM NEW | 13,393,905 | -1,491,309 | -10.0% | 0.86% | $774M | -$125M | 1.66% | $87.3B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: MRK | Current | Pharmaceutical Preparations | COM | 5,020,532 | -1,764,476 | -26.0% | 0.20% | $730M | -$142M | 1.57% | $327B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: SPCX | Current | Services-Computer Programming, Data Processing, Etc. | CLASS A COM STK | 4,829,713 | +4,829,713 | New | $729M | +$729M | 1.56% | $1.88T | Q3 2026 | 13 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: KO | Current | Beverages | COM | 8,282,702 | +63,082 | +0.8% | 0.19% | $713M | +$45M | 1.53% | $417B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: CI | Current | Hospital & Medical Service Plans | COM | 2,599,431 | +22,356 | +0.9% | 0.99% | $707M | -$4M | 1.52% | $71.4B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: ELV | Current | Hospital & Medical Service Plans | COM | 1,678,831 | -12,840 | -0.8% | 0.78% | $653M | -$1M | 1.40% | $84.3B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: KLAC | Current | Optical Instruments & Lenses | COM NEW | 3,212,950 | -680,943 | -17.5% | 0.25% | $626M | -$549M | 1.34% | $184B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Accenture PLC Ireland | Current | SHS CLASS A | 2,918,542 | -1,065,691 | -26.7% | $535M | +$39M | 1.15% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: UBER | Current | Services-Business Services, NEC | COM | 7,621,441 | +231,783 | +3.1% | 0.37% | $522M | -$11M | 1.12% | $130B | Q3 2026 | 13 Nov 2026 | Q1 2025 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: ISRG | Current | Orthopedic, Prosthetic & Surgical Appliances & Supplies | COM NEW | 1,249,187 | +21,194 | +1.7% | 0.36% | $508M | +$20M | 1.09% | $138B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: CRM | Current | Services-Prepackaged Software | COM | 2,194,705 | -2,233,228 | -50.4% | 0.27% | $504M | -$190M | 1.08% | $151B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: TJX | Current | Retail-Family Clothing Stores | COM | 3,720,257 | +41,069 | +1.1% | 0.34% | $492M | -$65M | 1.06% | $153B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: SNPS | Current | Services-Prepackaged Software | COM | 1,108,666 | +146,960 | +15.3% | 0.58% | $482M | +$53M | 1.03% | $82.6B | Q3 2026 | 13 Nov 2026 | Q1 2025 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: STZ | Current | Beverages | CL A | 4,047,029 | +48,604 | +1.2% | $458M | -$99M | 0.98% | $23.9B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: DGX | Current | Services-Medical Laboratories | COM | 1,930,280 | +42,073 | +2.2% | 1.75% | $450M | +$50M | 0.97% | $28.5B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: PM | Current | Cigarettes | COM | 1,980,562 | +1,204,645 | +155.3% | 0.13% | $378M | +$238M | 0.81% | $287B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: SYK | Current | Surgical & Medical Instruments & Apparatus | COM | 1,339,348 | +1,339,348 | New | 0.35% | $369M | +$369M | 0.79% | $118B | Q3 2026 | 13 Nov 2026 | Q1 2025 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: HLT | Current | Hotels & Motels | COM | 1,091,788 | -289,436 | -21.0% | 0.49% | $347M | -$109M | 0.75% | $79.3B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: TW | Current | Security & Commodity Brokers, Dealers, Exchanges & Services | CL A | 2,754,224 | +90,706 | +3.4% | $278M | +$12M | 0.60% | $27.1B | Q3 2026 | 13 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: MLM | Current | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | COM | 476,741 | +467,225 | +4909.9% | 0.67% | $229M | +$223M | 0.49% | $36.0B | Q3 2026 | 13 Nov 2026 | Q4 2024 | Q3 2026 | 13F, Q3 2026 | |
| Asml Hldg NV | Current | N Y REGISTRY SHS | 125,221 | -26,766 | -17.6% | $227M | -$76M | 0.49% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: HD | Current | Retail-Lumber & Other Building Materials Dealers | COM | 753,931 | +753,931 | New | 0.08% | $214M | +$214M | 0.46% | $336B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: GSK | Current | Pharmaceutical Preparations | SPONSORED ADR | 3,917,951 | +318,430 | +8.8% | $189M | +$0.0M | 0.40% | $95.9B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: TTE | Current | Crude Petroleum & Natural Gas | ACT | 2,088,043 | +532,479 | +34.2% | $179M | +$58M | 0.38% | $189B | Q3 2026 | 13 Nov 2026 | Q4 2025 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: RIO | Current | Metal Mining | SPONSORED ADR | 1,891,297 | +52,162 | +2.8% | $178M | +$4M | 0.38% | $121B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: TD | Current | Commercial Banks, NEC | COM NEW | 1,486,092 | -245,009 | -14.2% | $175M | -$35M | 0.38% | $188B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Deutsche BK AG | Current | NAMEN AKT | 4,592,639 | -696,239 | -13.2% | $166M | -$13M | 0.36% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: TSM | Current | Semiconductors & Related Devices | SPONSORED ADS | 361,604 | +32,058 | +9.7% | $165M | +$8M | 0.35% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: ARMK | Current | Retail-Eating Places | COM | 3,026,924 | +133,324 | +4.6% | 1.15% | $162M | -$3M | 0.35% | $14.5B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: VOD | Current | Radiotelephone Communications | SPONSORED ADR | 9,772,944 | -288,726 | -2.9% | $158M | +$25M | 0.34% | $33.5B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| BANK OF NOVA SCOTIA | NYSE: BNS | Current | State Commercial Banks | COM | 1,713,857 | +332,255 | +24.0% | $156M | +$36M | 0.33% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: PG | Current | Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics | COM | 944,757 | +8,149 | +0.9% | 0.04% | $137M | -$0.1M | 0.29% | $393B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Gmo Etf Trust | Current | Fund | DOMES RESIL ETF | 4,154,794 | +1,641,550 | +65.3% | $131M | +$45M | 0.28% | Q3 2026 | 13 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: MGA | Current | Motor Vehicle Parts & Accessories | COM | 1,904,574 | +355,775 | +23.0% | $121M | +$20M | 0.26% | $15.9B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: DAR | Current | Fats & Oils | COM | 1,727,546 | -572,936 | -24.9% | 1.12% | $105M | -$21M | 0.23% | $8.1B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: ALB | Current | Plastic Materials, Synth Resins & Nonvulcan Elastomers | COM | 951,540 | +54,527 | +6.1% | 0.81% | $101M | -$20M | 0.22% | $9.8B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: GE | Current | Electronic & Other Electrical Equipment (No Computer Equip) | COM NEW | 298,222 | +18,435 | +6.6% | 0.03% | $93M | -$11M | 0.20% | $330B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| CHEMICAL & MINING CO OF CHILE INC | NYSE: SQM | Current | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | SPON ADR SER B | 1,392,092 | -219,978 | -13.6% | $90M | -$29M | 0.19% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| SUN LIFE FINANCIAL INC | NYSE: SLF | Current | Life Insurance | COM | 1,112,393 | +444,659 | +66.6% | $87M | +$34M | 0.19% | $38.9B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: RUN | Current | Construction - Special Trade Contractors | COM | 9,497,351 | +1,492,669 | +18.6% | 3.93% | $74M | -$33M | 0.16% | $1.7B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| LSE: ULVR | Current | Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics | SPON ADR NEW | 1,215,105 | +562,419 | +86.2% | $74M | +$35M | 0.16% | $137B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: NXE | Current | Miscellaneous Metal Ores | COM | 7,997,531 | +405,328 | +5.3% | $73M | +$2M | 0.16% | $4.8B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: UBS | Current | National Commercial Banks | SHS | 1,467,707 | +159,000 | +12.1% | $71M | +$6M | 0.15% | $136B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| VERIZON COMMUNICATIONS INC | NYSE: VZ | Current | Telephone Communications (No Radiotelephone) | COM | 1,436,972 | +4,738 | +0.3% | 0.03% | $66M | +$5M | 0.14% | $190B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 |
| NYSE: PFE | Current | Pharmaceutical Preparations | COM | 2,264,670 | +85,353 | +3.9% | 0.04% | $65M | +$12M | 0.14% | $156B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| MANULIFE FINANCIAL CORP | NYSE: MFC | Current | Life Insurance | COM | 1,510,638 | +176,239 | +13.2% | $64M | +$10M | 0.14% | $69.7B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: QCOM | Current | Radio & Tv Broadcasting & Communications Equipment | COM | 339,749 | +98,562 | +40.9% | 0.03% | $63M | +$18M | 0.13% | $173B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: ARRY | Current | Semiconductors & Related Devices | COM SHS | 14,672,398 | +2,781,422 | +23.4% | 9.51% | $59M | -$29M | 0.13% | $646M | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Bank of Amer Corp | Current | COM | 1,046,391 | +3,718 | +0.4% | $57M | -$2M | 0.12% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: COP | Current | Petroleum Refining | COM | 452,242 | -123,137 | -21.4% | 0.04% | $57M | -$3M | 0.12% | $160B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: XOM | Current | Petroleum Refining | COM SHS | 341,507 | +341,507 | New | 0.01% | $56M | +$56M | 0.12% | Q3 2026 | 13 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: PBR | Current | Crude Petroleum & Natural Gas | SP ADR NON VTG | 2,882,932 | +448,352 | +18.4% | $55M | +$19M | 0.12% | $105B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| REGENERON PHARMACEUTICALS, INC. | Nasdaq: REGN | Current | Pharmaceutical Preparations | COM | 71,076 | -3,124 | -4.2% | $54M | +$8M | 0.12% | $95.5B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Hewlett Packard Enterprise Co | NYSE: HPE | Current | Computer & office Equipment | COM | 834,687 | -123,523 | -12.9% | 0.06% | $53M | +$10M | 0.11% | $60.4B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 |
| NYSE: EQH | Current | Insurance Agents, Brokers & Service | COM | 1,007,387 | +940,062 | +1396.3% | 0.38% | $52M | +$49M | 0.11% | $13.8B | Q3 2026 | 13 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |
| Gmo Etf Trust | Current | Fund | POWER INFRASTRUC | 2,180,468 | +2,180,468 | New | $51M | +$51M | 0.11% | Q3 2026 | 13 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: AMRC | Current | Construction - Special Trade Contractors | CL A | 2,412,024 | +381,074 | +18.8% | $50M | -$6M | 0.11% | $1.2B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Roper Technologies | Nasdaq: ROP | Current | Industrial Instruments For Measurement, Display, and Control | COM | 142,658 | -38,278 | -21.2% | 0.14% | $50M | -$11M | 0.11% | $45.8B | Q3 2026 | 13 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 |
| NYSE: C | Current | National Commercial Banks | COM NEW | 384,298 | -75,915 | -16.5% | $50M | -$15M | 0.11% | $183B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: ITRI | Current | Instruments For Meas & Testing of Electricity & Elec Signals | COM | 552,677 | +30,015 | +5.7% | 1.26% | $48M | +$2M | 0.10% | $4.3B | Q3 2026 | 13 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: ALL | Current | Fire, Marine & Casualty Insurance | COM | 212,414 | -1,944 | -0.9% | 0.09% | $47M | -$4M | 0.10% | $66.0B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: ADBE | Current | Services-Prepackaged Software | COM | 195,751 | +81,054 | +70.7% | 0.05% | $47M | +$23M | 0.10% | $84.7B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| CNH Indl N V | Current | SHS | 3,651,375 | -493,123 | -11.9% | $47M | +$0.4M | 0.10% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: CVS | Current | Retail-Drug Stores and Proprietary Stores | COM | 545,737 | +4,622 | +0.9% | 0.04% | $47M | -$9M | 0.10% | $102B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Essential Utilities, Inc. | NYSE: WTRG | Current | Water Supply | COM | 1,190,728 | +210,482 | +21.5% | 0.42% | $47M | +$9M | 0.10% | $12.9B | Q3 2026 | 13 Nov 2026 | Q1 2025 | Q3 2026 | 13F, Q3 2026 |
| NYSE: GIB | Current | Services-Management Consulting Services | CL A SUB VTG | 683,711 | +118,656 | +21.0% | $47M | +$10M | 0.10% | $16.0B | Q3 2026 | 13 Nov 2026 | Q4 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: BF.B | Current | Beverages | CL B | 1,770,759 | +104,115 | +6.2% | $46M | +$2M | 0.10% | $14.1B | Q3 2026 | 13 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: JKHY | Current | Services-Computer Integrated Systems Design | COM | 317,594 | -8,242 | -2.5% | 0.46% | $45M | +$0.6M | 0.10% | $11.9B | Q3 2026 | 13 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: COF | Current | National Commercial Banks | COM | 234,214 | +2,911 | +1.3% | 0.04% | $45M | -$1M | 0.10% | $107B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: VIST | Current | Crude Petroleum & Natural Gas | SPONSORED ADS | 672,409 | -63,500 | -8.6% | $44M | -$3M | 0.09% | $5.5B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: NUE | Current | Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens) | COM | 185,475 | -17,760 | -8.7% | 0.08% | $43M | -$2M | 0.09% | $55.7B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| California Resources Corp | NYSE: CRC | Current | Crude Petroleum & Natural Gas | COM STOCK | 853,369 | -54,292 | -6.0% | 0.97% | $43M | -$5M | 0.09% | $3.9B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 |
| Nasdaq: GPRE | Current | Industrial Organic Chemicals | COM | 2,818,338 | -1,080,629 | -27.7% | 3.99% | $42M | -$18M | 0.09% | $823M | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: PYPL | Current | Services-Business Services, NEC | COM | 807,704 | -29,824 | -3.6% | 0.10% | $42M | +$6M | 0.09% | $44.3B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: NSC | Current | Railroads, Line-Haul Operating | COM | 137,030 | +13,329 | +10.8% | 0.06% | $42M | +$3M | 0.09% | $71.2B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: CMCSA | Current | Cable & Other Pay Television Services | CL A | 1,912,403 | +192,534 | +11.2% | $42M | -$0.6M | 0.09% | $88.3B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: HPQ | Current | Computer & office Equipment | COM | 1,296,715 | -71,703 | -5.2% | 0.14% | $41M | +$11M | 0.09% | $25.2B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: NVS | Current | Pharmaceutical Preparations | SPONSORED ADR | 281,714 | +35,757 | +14.5% | $40M | +$2M | 0.09% | $286B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Solaredge Technologies Inc | Current | COM | 1,224,396 | -19,399 | -1.6% | $39M | -$34M | 0.08% | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| Nextpower | Nasdaq: NXT | Current | Semiconductors & Related Devices | COM | 492,855 | +175,942 | +55.5% | 0.33% | $38M | +$0.7M | 0.08% | $11.6B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 |
| NYSE: TXNM | Current | Electric Services | COM | 658,116 | -30,868 | -4.5% | 0.59% | $38M | -$0.7M | 0.08% | $6.5B | Q3 2026 | 13 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: CTSH | Current | Services-Computer Programming Services | CL A | 667,921 | +850 | +0.1% | 0.15% | $38M | +$13M | 0.08% | $25.2B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: UPS | Current | Trucking & Courier Services (No Air) | CL B | 407,279 | -43,033 | -9.6% | $38M | -$10M | 0.08% | $92.9B | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: OTIS | Exited | Electronic & Other Electrical Equipment (No Computer Equip) | COM | 0 | -5,460,836 | -100.0% | -$564M | $29.0B | Q2 2025 | 13 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||
| Nasdaq: WWD | Exited | Electrical Industrial Apparatus | COM | 0 | -217,107 | -100.0% | -$55M | $19.8B | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||
| Nasdaq: ENPH | Exited | Semiconductors & Related Devices | COM | 0 | -481,748 | -100.0% | -$54M | $2.9B | Q4 2024 | 13 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| MR Cooper Group Inc | Exited | COM | 0 | -183,104 | -100.0% | -$51M | Q3 2025 | 13 Nov 2025 | Q4 2024 | Q2 2025 | 13F, Q2 2025 | ||||||
| NYSE: WFG | Exited | Sawmills & Planting Mills, General | COM | 0 | -502,423 | -100.0% | -$49M | $4.9B | Q4 2024 | 13 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| Hess Corp | Exited | COM | 0 | -305,026 | -100.0% | -$49M | Q2 2025 | 13 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||||
| Discover Finl Svcs | Exited | COM | 0 | -277,394 | -100.0% | -$48M | Q1 2025 | 14 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||||
| NYSE: CNC | Exited | Hospital & Medical Service Plans | COM | 0 | -783,671 | -100.0% | -$48M | $32.5B | Q2 2025 | 13 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||
| Walgreens Boots Alliance Inc | Exited | COM | 0 | -4,219,316 | -100.0% | -$47M | Q2 2025 | 13 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||||
| United States STL Corp New | Exited | COM | 0 | -1,319,011 | -100.0% | -$47M | Q4 2024 | 13 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| Webster Finl Corp | Exited | COM | 0 | -591,218 | -100.0% | -$45M | Q3 2026 | 13 Nov 2026 | Q1 2026 | Q2 2026 | 13F, Q2 2026 | ||||||
| British American Tobacco p.l.c. | NYSE: BTI | Exited | Cigarettes | SPONSORED ADR | 0 | -766,683 | -100.0% | -$45M | $123B | Q2 2026 | 13 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | |||
| Nasdaq: ON | Exited | Semiconductors & Related Devices | COM | 0 | -709,652 | -100.0% | -$45M | $25.6B | Q1 2025 | 14 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||
| NYSE: B | Exited | Gold and Silver Ores | COM SHS | 0 | -986,183 | -100.0% | -$43M | $54.3B | Q1 2026 | 14 May 2026 | Q3 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| NYSE: VALE | Exited | Metal Mining | SPONSORED ADS | 0 | -2,632,354 | -100.0% | -$42M | $41.8B | Q2 2026 | 13 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| Exxon Mobil | Exited | COM | 0 | -297,503 | -100.0% | -$41M | Q3 2026 | 13 Nov 2026 | Q3 2024 | Q2 2026 | 13F, Q2 2026 | ||||||
| Azek Co Inc | Exited | CL A | 0 | -745,471 | -100.0% | -$41M | Q3 2025 | 13 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | ||||||
| Masimo Corp | Exited | COM | 0 | -240,563 | -100.0% | -$40M | Q3 2025 | 13 Nov 2025 | Q2 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| Liberty Broadband Corp | Exited | COM SER C | 0 | -633,246 | -100.0% | -$40M | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||||
| Comerica Inc | CMA | Exited | COM | 0 | -423,815 | -100.0% | -$37M | Q1 2026 | 14 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | |||||
| Magnum Ice Cream Co NV | Exited | ORD SHS | 0 | -2,219,681 | -100.0% | -$35M | Q1 2026 | 14 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 |
| GMO Quality Fund | GQEFX, GQESX, GQETX, GQLFX, GQLIX, GQLOX | Mutual fund | Active | $11.2B | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO U.S. Quality ETF | QLTY | ETF | Active | $2.8B | 28 Feb 2026 | Adviser | GMO ETF Trust |
| Diversified Income Fund | PGBAX, PGBLX, PGDCX, PGDIX | Mutual fund | Active | $2.5B | 31 Oct 2025 | Sub-adviser | Principal Funds, Inc. |
| GMO Emerging Country Debt Fund | GMCDX, GMDFX, GMOQX | Mutual fund | Active | $2.4B | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Benchmark-Free Allocation Fund | GBMBX, GBMFX, GBMIX, GBMSX | Mutual fund | Fund of funds | $2.4B | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Implementation Fund | GIMFX | Mutual fund | Active | $2.1B | 28 Feb 2026 | Adviser | GMO TRUST |
| SIIT EMERGING MARKETS DEBT FUND | SEDAX | Mutual fund | Active | $1.8B | 31 May 2026 | Sub-adviser | SEI INSTITUTIONAL INVESTMENTS TRUST |
| Aspiriant Risk-Managed Equity Allocation Fund | RMEAX, RMEIX | Mutual fund | Active | $1.4B | 31 Mar 2026 | Sub-adviser | Aspiriant Trust |
| GMO Opportunistic Income Fund | GAAAX, GMODX, GMOHX, GMOLX | Mutual fund | Active | $1.3B | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Resources Fund | GAAHX, GEACX, GMOWX, GOFIX, GOVIX | Mutual fund | Active | $1.3B | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Benchmark-Free Fund | GBFFX | Mutual fund | Active | $1.2B | 28 Feb 2026 | Adviser | GMO TRUST |
| Tax-Managed Real Assets Fund | RTXAX, RTXCX, RTXMX, RTXSX | Mutual fund | Active | $1.1B | 31 Oct 2025 | Sub-adviser | RUSSELL INVESTMENT CO |
| GMO International Equity Fund | GMCFX, GMOIX, GMOUX | Mutual fund | Active | $1.0B | 28 Feb 2026 | Adviser | GMO TRUST |
| SIT Emerging Markets Debt Fund | SIEDX, SITEX | Mutual fund | Active | $919M | 30 Sep 2025 | Sub-adviser | SEI INSTITUTIONAL INTERNATIONAL TRUST |
| GMO Alternative Allocation Fund | GAAGX, GAAKX, GAAVX | Mutual fund | Active | $722M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Global Equity Allocation Fund | GAAUX, GMADX, GMGEX | Mutual fund | Fund of funds | $597M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Small Cap Quality Fund | GMAWX, GMAYX, GMBVX, GMSQX, GSBGX | Mutual fund | Active | $572M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Climate Change Fund | GCCAX, GCCHX, GCCLX | Mutual fund | Active | $491M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Emerging Markets Fund | GEMEX, GEMMX, GEMNX, GEMVX, GMEFX, GMEMX, GMOEX | Mutual fund | Active | $445M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Global Asset Allocation Fund | GMOOX, GMWAX, GMWRX | Mutual fund | Fund of funds | $444M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO U.S. Treasury Fund | GUSTX | Mutual fund | Active | $393M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO U.S. Opportunistic Value Fund | GUSOX, PPADX, PPAEX, PPAJX, UUOAX | Mutual fund | Active | $355M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO International Equity Allocation Fund | GIEAX, GSXMX | Mutual fund | Fund of funds | $353M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO International Opportunistic Value Fund | GMAZX, GMBCX, GTMIX, IOVFX | Mutual fund | Active | $343M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO International Developed Equity Allocation Fund | GAAWX, GIOTX | Mutual fund | Fund of funds | $245M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO International Value ETF | GMOI | ETF | Active | $244M | 28 Feb 2026 | Adviser | GMO ETF Trust |
| Dunham Monthly Distribution Fund | DAMDX, DCMDX, DNMDX | Mutual fund | Active | $243M | 31 Oct 2025 | Sub-adviser | Dunham Funds |
| GMO-Usonian Japan Value Creation Fund | GMAHX, GMAKX, GMIIX | Mutual fund | Active | $208M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO U.S. Equity Fund | GMCQX, GMEQX, GMRTX, GMUEX | Mutual fund | Active | $194M | 28 Feb 2026 | Adviser | GMO TRUST |
| LS Opportunity Fund | LSOFX | Mutual fund | Active | $152M | 31 May 2026 | Sub-adviser | Valued Advisers Trust |
| GMO International Quality ETF | QLTI | ETF | Active | $151M | 28 Feb 2026 | Adviser | GMO ETF Trust |
| GMO High Yield Fund | GHVIX, GMOZX | Mutual fund | Active | $137M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Resource Transition Fund | GMOCX, GMOYX | Mutual fund | Active | $126M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Strategic Opportunities Allocation Fund | GBATX | Mutual fund | Active | $102M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Multi-Asset Credit Fund | GMCHX, GMIQX, GMRQX | Mutual fund | Fund of funds | $98M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Global Developed Equity Allocation Fund | GWOAX | Mutual fund | Fund of funds | $88M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Emerging Markets ex-China Fund | GMAQX, GMAUX, GMAVX | Mutual fund | Active | $80M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO U.S. Value ETF | GMOV | ETF | Active | $62M | 28 Feb 2026 | Adviser | GMO ETF Trust |
| GMO Asset Allocation Bond Fund | GABFX, GMOBX | Mutual fund | Active | $47M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO U.S. Small Cap Value Fund | GCAVX | Mutual fund | Active | $38M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Domestic Resilience ETF | DRES | ETF | Active | $31M | 28 Feb 2026 | Adviser | GMO ETF Trust |
| GMO Emerging Country Debt Shares Fund | GMAFX, GMAJX | Mutual fund | Active | $26M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Dynamic Allocation ETF | GMOD | ETF | Active | $20M | 28 Feb 2026 | Adviser | GMO ETF Trust |
| GMO Systematic Investment Grade Credit ETF | INVG | ETF | Active | $15M | 28 Feb 2026 | Adviser | GMO ETF Trust |
| GMO MAC Implementation Fund | GMIHX | Mutual fund | Active | $14M | 28 Feb 2026 | Adviser | GMO TRUST |
| GMO Beyond China ETF | BCHI | ETF | Active | $13M | 28 Feb 2026 | Adviser | GMO ETF Trust |
| GMO Ultra-Short Income ETF | GMOC | ETF | Active | $8M | 28 Feb 2026 | Adviser | GMO ETF Trust |
| Valuing AI: Extreme Bubble, New Golden Era - or Both? | Jeremy Grantham and Edward Chancellor test whether AI is a two-sigma bubble or a paradigm shift, measured against over 300 historical bubbles across asset classes. | 2026 | ||
| Rising Toxicity and the Threat to Capitalism and Life Itself | Jeremy Grantham argues that toxicity from untested chemicals is this century's most underrecognised threat, driving a fertility crisis and harming health. | 2025 | ||
| The Great Paradox of the U.S. Market | Jeremy Grantham argues U.S. stock prices, at a Shiller P/E of 34 in the top 1% of history, price in perfection while the world is imperfect and dangerous. | 2024 | 2024-02-04 | |
| Sustainability or Bust: The Sheer Impossibility of Eternal Compound Growth | Jeremy Grantham argues compound growth cannot last forever as workforces shrink, resources grow scarcer and climate damage escalates. | 2024 | ||
| After a Timeout, Back to the Meat Grinder | Jeremy Grantham says the first leg of the bubble's bursting is over, with speculative growth stocks crushed, and expects further losses. | 2023 | 2023-01-24 | |
| Entering the Superbubble's Final Act | Jeremy Grantham argues the U.S. superbubble has entered its final act, comparing it with the Nifty Fifty, 1929, 2000 and 2006. | 2022 | 2022-08-31 | |
| Let the Wild Rumpus Begin | Jeremy Grantham argues the U.S. is in its fourth superbubble, after 1929, 2000 and Japan in 1989, and that superbubbles correct back to trend with great pain. | 2022 | 2022-01-20 | |
| Putin's Invasion Reminds Us That We Live in a Finite World | Jeremy Grantham argues Russia's invasion of Ukraine shows a finite world, where decarbonisation needs scarce commodities and the war adds pressure on raw materials. | 2022 | ||
| Waiting for the Last Dance | Jeremy Grantham argues the bull market since 2009 has become an epic bubble, alongside the South Sea bubble, 1929 and 2000, and warns asset allocators. | 2021 | 2021-01-05 | |
| Waiting for the Last Dance (revised, September 2021) | Jeremy Grantham's revised September 2021 version of Waiting for the Last Dance calls the U.S. market an epic bubble featuring frenzied issuance and speculation. | Q3 2021 | ||
| Covid-19, Climate Change, and the Need for a New Marshall Plan | Jeremy Grantham urges a new Marshall Plan for climate infrastructure, arguing low growth, inequality and negative real rates make 2020 the time for it. | 2020 | 2020-10-30 | |
| Chemical Toxicity and the Baby Bust | Jeremy Grantham argues chemical toxicity is a neglected cause of falling fertility and a threat to chemical companies. | 2020 | ||
| Bracing Yourself for a Possible Near-Term Melt-Up | Jeremy Grantham, a value investor, warns in January 2018 of a possible near-term melt-up, as the U.S. market shows signs of a classic bubble's final phase. | 2018 | 2018-01-03 | |
| This Time Seems Very, Very Different / The US Market Will Revert | Jeremy Grantham clarifies that he expects the U.S. market to revert toward its old means, but very slowly, after journalists misquoted him. | 2017 | 2017-06-29 | |
| The Race of Our Lives | Jeremy Grantham argues the global economy, reckless with resources, shows signs of failure that brought down past civilisations, in a race against time. | 2013 | ||
| My Sister's Pension Assets and Agency Problems | Jeremy Grantham argues career risk drives professional investors to protect their jobs rather than clients' money, using his sister's pension as an example. | 2012 | ||
| Time to Wake Up: Days of Abundant Resources and Falling Prices Are Over Forever (1Q 2011) | Jeremy Grantham argues the days of abundant resources and falling commodity prices are over forever, and investors must change their thinking. | Q1 2011 | ||
| Summer Essays (GMO Quarterly Letter, 2Q 2010) | Jeremy Grantham's summer 2010 essays cover GMO's portfolio outlook, finance going rogue, a fearful speculative market and global warming. | Q2 2010 | ||
| Reinvesting When Terrified | Jeremy Grantham urges investors in March 2009 to reinvest when terrified, as painful as it was to sell in 1999. | 2009 | ||
| It's Everywhere, In Everything (GMO Quarterly Letter, 4Q 2007) | Jeremy Grantham calls the boom in everything from Indian antiquities to junk bonds the first truly global bubble. | Q4 2007 |
How the London money market worked, and why a central bank lends freely in a panic.
“The good times too of high price almost always engender much fraud,” wrote Walter Bagehot in Lombard Street: A Description of the Money Market (1877).” — Jeremy Grantham
Source: Valuing AI: Extreme Bubble, New Golden Era - or Both?, page 13
Speculation from ancient Rome and tulip mania to the 1990s, and its recurring traits.
“(It’s economical, he says, because he will reuse most of it in an upcoming update to his seriously useful classic, Devil Take The Hindmost: A History of Financial Speculation (1999).)” — Jeremy Grantham
Source: Valuing AI: Extreme Bubble, New Golden Era - or Both?, page 2
Also recommended by: Howard Marks, John C. Bogle, Mohnish Pabrai and 2 others
The late-1920s boom in margin loans and investment trusts, and the 1929 crash.
“In his book, The Great Crash 1929 (1955), the American economist J.K. Galbraith coined the term “bezzle,” which he defined as “an inventory of undiscovered embezzlement in—or more precisely not in—the country’s businesses and banks.” — Jeremy Grantham
Source: Valuing AI: Extreme Bubble, New Golden Era - or Both?, page 13
Also recommended by: Howard Marks, Mohnish Pabrai, Warren Buffett
Crowd manias from the Mississippi scheme and South Sea Bubble to witch trials.
“We find whole communities suddenly fix their minds upon one object, and go mad in its pursuit,” wrote Charles Mackay in Extraordinary Popular Delusions and the Madness of Crowds (1841), which contains descriptions of early speculative manias.” — Jeremy Grantham
Source: Valuing AI: Extreme Bubble, New Golden Era - or Both?, page 6
Also recommended by: Barton Biggs, Bernard Baruch, John C. Bogle and 4 others
How financial innovation made markets more crisis-prone, from a risk manager.
“From the title of the excellent book by Richard Bookstaber.” — Jeremy Grantham
Source: Let the Wild Rumpus Begin, page 6
Also recommended by: Howard Marks, Michael Mauboussin
The costs and benefits of a shrinking world population.
“A favorite book on the topic is Empty Planet: The Shock of Global Population Decline, by Darrell Bricker and John Ibbitson, and a recommended YouTube video, if you prefer, is “Birthgap – Childless World Part 1,” Birthgap.org (2022).” — Jeremy Grantham
Source: Rising Toxicity and the Threat to Capitalism and Life Itself, page 8
How new technologies have moved markets and industries, for investors.
“In his book, Engines That Move Markets: Technology Investing from Railroads to the Internet and Beyond (2001), Alasdair Nairn describes their common characteristics, which provide a useful template to gauge the market’s current embrace of AI.” — Jeremy Grantham
Source: Valuing AI: Extreme Bubble, New Golden Era - or Both?, page 3
Why the race to build superhuman AI could lead to human extinction.
“As to what happens if (or when) AI becomes far more intelligent than us, the recent book, If Anyone Builds It, Everyone Dies (Yudkowsky and Soares 2025), is a chilling and very persuasive read.” — Jeremy Grantham
Source: Valuing AI: Extreme Bubble, New Golden Era - or Both?, page 2
Why civilizations collapse from their own size and the biophysical limits they meet.
“Very recently, one of these scholars, William Ophuls, wrote a new book, Immoderate Greatness1 (a quote from Gibbons’s Decline and Fall of the Roman Empire), with the subtitle Why Civilizations Fail. It is a straightforward summary and synthesis of all of the ways to fail in 70 small pages, yet with extensive notes and references.” — Jeremy Grantham
Source: The Race of Our Lives, page 1
How synthetic chemicals disrupt the hormones that control growth and fertility.
“For much more information, several excellent books that are accessible enough to laymen have been written on these topics in recent years. These include Sicker Fatter Poorer by Leonardo Trasande (2019), Count Down by Shanna Swan and Stacey Colino (2021), The Obesogen Effect by Bruce Blumberg and Kristin Loberg (2018), Toxic Cocktail by Barbara Demeneix (2017), and Our Stolen Future by Dianne Dumanoski, John Peterson Myers, and Theo …” — Jeremy Grantham
Source: Rising Toxicity and the Threat to Capitalism and Life Itself, page 3
How hormone-disrupting chemicals harm our health, and what we can do about it.
“For much more information, several excellent books that are accessible enough to laymen have been written on these topics in recent years. These include Sicker Fatter Poorer by Leonardo Trasande (2019), Count Down by Shanna Swan and Stacey Colino (2021), The Obesogen Effect by Bruce Blumberg and Kristin Loberg (2018), Toxic Cocktail by Barbara Demeneix (2017), and Our Stolen Future by Dianne Dumanoski, John Peterson Myers …” — Jeremy Grantham
Source: Rising Toxicity and the Threat to Capitalism and Life Itself, page 3
How environmental chemicals may help cause the obesity epidemic.
“For much more information, several excellent books that are accessible enough to laymen have been written on these topics in recent years. These include Sicker Fatter Poorer by Leonardo Trasande (2019), Count Down by Shanna Swan and Stacey Colino (2021), The Obesogen Effect by Bruce Blumberg and Kristin Loberg (2018), Toxic Cocktail by Barbara Demeneix (2017), and Our Stolen Future by Dianne Dumanoski, John Peterson Myers …” — Jeremy Grantham
Source: Rising Toxicity and the Threat to Capitalism and Life Itself, page 3
How thyroid-disrupting chemicals may lower children's IQ and raise autism and ADHD.
“For much more information, several excellent books that are accessible enough to laymen have been written on these topics in recent years. These include Sicker Fatter Poorer by Leonardo Trasande (2019), Count Down by Shanna Swan and Stacey Colino (2021), The Obesogen Effect by Bruce Blumberg and Kristin Loberg (2018), Toxic Cocktail by Barbara Demeneix (2017), and Our Stolen Future by Dianne Dumanoski, John Peterson Myers …” — Jeremy Grantham
Source: Rising Toxicity and the Threat to Capitalism and Life Itself, page 3
Five centuries of financial and religious manias, and why people go mad in groups.
“Narratives, says William Bernstein, author of The Delusions of Crowds: Why People Go Mad in Groups (2021), are “the pathogens that spread the bubble disease throughout a society.” — Jeremy Grantham
Source: Valuing AI: Extreme Bubble, New Golden Era - or Both?, page 4
Also recommended by: Michael Mauboussin
How modern chemicals and habits disrupt hormones and lower sperm counts.
“These include Sicker Fatter Poorer by Leonardo Trasande (2019), Count Down by Shanna Swan and Stacey Colino (2021), The Obesogen Effect by Bruce Blumberg and Kristin Loberg (2018), Toxic Cocktail by Barbara Demeneix (2017), and Our Stolen Future by Dianne Dumanoski, John Peterson Myers, and Theo Colborn (1996).” — Jeremy Grantham
Source: Rising Toxicity and the Threat to Capitalism and Life Itself, page 3
Also recommended by: Nat Eliason